Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan

Tobacco Control

Volumn 16, Issue 6, 2007, Pages 394-399

  Chung, Chih Wen ^b   Wang, Jung Der ^b,c   Yu, Cheng Fen ^b   Yang, Ming Chin ^a,b  

^a National Taiwan University ^*  (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASM; RISK FACTOR; SMOKING; STROKE; SURVIVAL; TAIWAN;

ADULT; AGED; COSTS AND COST ANALYSIS; FEMALE; HEALTH EXPENDITURES; HUMANS; INSURANCE, HEALTH; LIFE EXPECTANCY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; STROKE; SURVIVAL ANALYSIS; TAIWAN;

EID: 37349095654     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2006.018986     Document Type: Article

References (18)

1. Mackay J, Eriksen M. The tobacco atlas. Geneva: World Health Organization, 2002.
2. Izumi Y, Tsuji I, Ohkubo T, et al. Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan. Int J Epidemiol 2001;30:616-21.
3. Warner KE, Hodgson TA, Carrol CE. Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control 1999;8:290-300.
4. Max W. The financial impact of smoking on health-related costs: a review of the literature. Am J Health Promot 2001;15:321-31.
5. Center for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States 1995-1999. MMWR Morb Mortal Wkly Rep 2002;51:300-3.
6. Yang MC, Fan CY, Wen CP, et al. Smoking-attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control, 2005;14(suppl 1), i62-i70.
7. Wen CP, Tsai SP, Chen CJ, et al. The mortality risk of smokers in Taiwan. Part I: Cause-specific mortality. Prev Med 2004;39:528-35.
8. Department of Health. Cancer registry annual report, 2001. Taiwan: Bureau of Health Promotion, DoH, 2004.
9. Hwang JS, Wang JD. Monte Carlo estimation of expected quality-adjusted survival for follow-up studies. Stat Med 1999;18:1627-40.
10. Department of Health. Health and vital statistics 2004-1. General health statistics. Taiwan: DoH, 2005.
11. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programs, Chapter 4:Cost analysis. Oxford: Oxford University Press, 2005.
12. Central Bank of Taiwan. Exchange rates of the NT dollar against the US dollar. Interbank Spot Market Closing Rates, 2006. www.cbc.gov.lw/ EngHome/Eforeign/Statistics/Eyearly.asp (last accessed on 19 Sept 2006).
13. Ministry of Finance, National Treasury Agency, Issuance Information of Central Government Bonds in Taiwan, 2006. www.nta.gov.tw/business/business204. asp (last accessed on 19 Sept 2006).
14. Guindon GE, Tobin S, Yach D. Trends and affordability of cigarette prices: ample room for tax increases and related health gains. Tob Control 2002;11:35-43.
15. Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Eng J Med 1997;337:1052-7.
16. Brannum-Hansen H, Juel K. Abstention from smoking extends life and compresses morbidity: a population based study of health expectancy among smokers and never smokers in Denmark. Tob Control 2001;10:273-8.
17. Hwang JS, Wang JD. Integrating health profile with survival for quality of life assessment. Qual Life Res 2004;13:1-10.
18. Jaakkola J, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health 2004;94:136-40.